```html

Kidney Failure (Chronic Kidney Disease) – A Patient‑Focused Guide

Overview

Chronic kidney disease (CKD), often referred to as kidney failure when it reaches an advanced stage, is a progressive loss of kidney function lasting three months or more. The kidneys filter waste, excess fluid, and electrolytes from the blood; when they can’t perform this task, toxins build up and many bodily systems are affected.

• Who it affects: CKD can develop at any age, but its prevalence rises sharply after age 50. Women and men are affected equally, though certain risk groups (e.g., African‑American, Hispanic, and Native American populations) have higher rates.
• Prevalence: According to the US Centers for Disease Control and Prevention (CDC), about 15% of US adults—~37 million people—have CKD. Worldwide, the International Society of Nephrology estimates >850 million people have some degree of CKD, making it the 12th leading cause of death globally.<sup>1</sup>
• Stages: CKD is classified into five stages based on the estimated glomerular filtration rate (eGFR). Stage 5 (eGFR < 15 mL/min/1.73 m²) is termed end‑stage renal disease (ESRD) or kidney failure and usually requires dialysis or a kidney transplant.

Symptoms

Early CKD is often silent, which is why routine screening is crucial for at‑risk individuals. As kidney function declines, a range of symptoms may appear. Not every person experiences all of them, and severity can vary.

General symptoms

• Fatigue & weakness: Reduced erythropoietin production leads to anemia, causing persistent tiredness.
• Decreased appetite & nausea: Accumulation of uremic toxins irritates the gastrointestinal tract.
• Weight loss: Often a consequence of poor appetite and muscle wasting.
• Itching (pruritus): Hyperphosphatemia and calcium‑phosphate crystal deposition in the skin.

Urinary changes

• Increased frequency, especially at night (nocturia): Impaired concentrating ability.
• Foamy or bubbly urine: Suggests proteinuria (protein leakage).
• Blood in urine (hematuria): May indicate glomerular disease.
• Decreased urine output (oliguria): Common in advanced stages.

Cardiovascular & fluid‑related signs

• Swelling (edema): Typically in the ankles, feet, and sometimes the face due to fluid retention.
• Shortness of breath: Fluid accumulation in the lungs (pulmonary edema) or anemia.
• High blood pressure: Both a cause and a result of CKD.

Metabolic disturbances

• Muscle cramps & restless legs: Calcium‑phosphate imbalance.
• Bone pain: Renal osteodystrophy from altered vitamin D metabolism.
• Changes in taste or metallic flavor: Uremia.

Causes and Risk Factors

CKD results from damage to the nephrons (functional kidney units) over time. The two most common underlying diseases are:

• Diabetes mellitus: High blood glucose damages glomerular capillaries. In the United States, diabetes accounts for ~44% of CKD cases.<sup>2</sup>
• Hypertension (high blood pressure): Elevated pressure injures blood vessels in the kidneys, responsible for ~28% of cases.

Other notable causes

• Glomerulonephritis (autoimmune or infection‑related inflammation)
• Polycystic kidney disease (genetic)
• Obstructive uropathy (stones, enlarged prostate, tumors)
• Prolonged use of nephrotoxic drugs (NSAIDs, certain antibiotics, contrast agents)
• Recurrent urinary tract infections

Risk factors that increase the likelihood of developing CKD

• Age > 50 years
• Family history of kidney disease
• African‑American, Hispanic, Native American, or Asian ancestry
• Obesity (BMI ≥ 30 kg/m²)
• Smoking
• Cardiovascular disease or heart failure
• Chronic viral infections (HIV, hepatitis B/C)
• Low socioeconomic status (limited access to preventive care)

Diagnosis

Because early disease often lacks symptoms, CKD is diagnosed through screening tests and a thorough medical history.

Laboratory tests

• eGFR (estimated glomerular filtration rate): Calculated from serum creatinine, age, sex, and race. eGFR < 60 mL/min/1.73 m² for ≥3 months indicates CKD.
• Urine albumin‑to‑creatinine ratio (ACR): Detects proteinuria. Values >30 mg/g signal kidney damage.
• Serum electrolytes & metabolic panel: Looks for hyperkalemia, metabolic acidosis, calcium‑phosphate disturbances.
• Complete blood count (CBC): Checks for anemia.
• Blood urea nitrogen (BUN): Elevated in reduced kidney clearance.

Imaging studies

• Renal ultrasound: Evaluates kidney size, obstruction, cysts.
• CT or MRI (with contrast only when necessary): Provides detailed anatomy for complex cases.

Specialist assessments

• Kidney biopsy: Reserved for unclear etiology (e.g., suspected glomerulonephritis).
• Referral to a nephrologist: Recommended when eGFR < 30 mL/min/1.73 m², rapid decline, or significant proteinuria.

Treatment Options

Treatment aims to slow progression, manage complications, and ultimately replace kidney function when necessary.

Medications

• ACE inhibitors (e.g., lisinopril) or ARBs (e.g., losartan): Lower blood pressure and reduce proteinuria; proven to slow CKD progression.<sup>3</sup>
• Blood‑pressure agents: Calcium channel blockers, beta‑blockers, or diuretics as adjuncts.
• Ferric citrate or phosphate binders (e.g., sevelamer): Control hyperphosphatemia.
• Vitamin D analogs (calcitriol, paricalcitol): Manage secondary hyperparathyroidism.
• Erythropoiesis‑stimulating agents (ESA): Treat anemia when hemoglobin <10 g/dL.
• Potassium‑binders (e.g., patiromer): Prevent dangerous hyperkalemia, especially when on ACE/ARB.
• SGLT2 inhibitors (e.g., dapagliflozin): Recent trials show they reduce CKD progression in diabetics and non‑diabetics.<sup>4</sup>

Renal replacement therapies

• Hemodialysis: Blood is filtered through an external machine 3 times per week.
• Peritoneal dialysis: A catheter delivers dialysate into the abdominal cavity to absorb waste.
• Kidney transplantation: The preferred long‑term solution; offers better quality of life and survival than dialysis.

Lifestyle modifications

• Maintain blood pressure < 130/80 mmHg (per KDIGO recommendations).
• Control blood glucose (A1C < 7% for most diabetics).
• Adopt a renal‑friendly diet: limit sodium (<2 g/day), moderate protein (0.6‑0.8 g/kg/day), restrict potassium and phosphorus if labs dictate.
• Quit smoking; limit alcohol.
• Engage in regular physical activity (≥150 min/week of moderate‑intensity aerobic exercise).
• Stay hydrated but avoid excessive fluid intake if fluid overload is an issue.

Living with Kidney Failure (Chronic Kidney Disease)

Beyond medical treatment, daily self‑care can markedly improve outcomes.

Monitoring

• Track blood pressure at home; keep a log for your provider.
• Weigh yourself daily; a sudden increase of >2 kg may indicate fluid retention.
• Check blood glucose if diabetic—use a glucometer or continuous monitor.
• Attend routine labs every 3–6 months (eGFR, ACR, electrolytes, hemoglobin).

Dietary tips

• Sodium: Flavor foods with herbs, spices, lemon juice instead of salt.
• Protein: Choose high‑quality sources (lean poultry, fish, egg whites) and keep portions modest.
• Phosphorus: Limit processed foods, cola drinks, and dairy; read food labels for “phosphate” additives.
• Potassium: If advised to restrict, avoid bananas, oranges, tomatoes, potatoes; opt for apples, berries, cauliflower.

Medication management

• Use a weekly pill organizer.
• Never skip doses of ACE/ARBs or diuretics without consulting your doctor.
• Inform every healthcare provider that you have CKD (including dentists).

Emotional & social support

• Join a CKD support group—sharing experiences reduces isolation.
• Consider counseling if anxiety or depression arises; chronic illness is a known risk factor.
• Plan for work accommodations if dialysis or frequent appointments are needed.

Prevention

Because many causes are modifiable, preventive measures focus on lifestyle and early detection.

• Screen high‑risk adults (diabetes, hypertension, age > 50, family history) with eGFR and urine ACR at least annually.
• Maintain a healthy weight (BMI 20‑25 kg/m²).
• Adopt a DASH‑style diet—rich in fruits, vegetables, whole grains, low‑fat dairy, and low in saturated fat.
• Quit smoking; nicotine worsens vascular injury.
• Limit NSAIDs to short courses; ask physicians about safer pain alternatives.
• Control blood pressure and blood sugar aggressively.
• Vaccinate against hepatitis B and influenza—these infections can worsen kidney function.

Complications

If CKD progresses unchecked, multiple organ systems can be affected.

• Cardiovascular disease: Leading cause of death in CKD; includes heart failure, coronary artery disease, and sudden cardiac death.
• Anemia: Reduced erythropoietin leads to fatigue and may require ESA therapy.
• Bone and mineral disorders: Renal osteodystrophy, vascular calcification, and fractures.
• Electrolyte abnormalities: Hyperkalemia, metabolic acidosis, hyponatremia.
• Fluid overload: Pulmonary edema, peripheral edema, hypertension.
• Infections: Impaired immunity and frequent dialysis access increase risk.
• Pregnancy complications: Preeclampsia, preterm birth, worsening renal function.

When to Seek Emergency Care

---

Sources:

1. International Society of Nephrology. Global Kidney Health Atlas 2023.
2. CDC. Chronic Kidney Disease in the United States, 2022.
3. KDOQI Clinical Practice Guidelines for Diabetes and CKD, National Kidney Foundation, 2023.
4. Neuen BV et al. SGLT2 Inhibitors for CKD: A Systematic Review. NEJM. 2024.
5. Mayo Clinic. Chronic kidney disease – Symptoms and causes. Accessed May 2026.

```